Ready-to-Use Therapeutic Food for Catch-Up Growth in Children after an Episode of Plasmodium falciparum Malaria: An Open Randomised Controlled Trial by van der Kam, Saskia et al.
Ready-to-Use Therapeutic Food for Catch-Up Growth in
Children after an Episode of Plasmodium falciparum
Malaria: An Open Randomised Controlled Trial
Saskia van der Kam
1*, Todd Swarthout
1, Oscar Niragira
2, Alyson Froud
1, Eric Mukomena Sompwe
3,
Clair Mills
4, Stephanie Roll
5, Peter Tinnemann
5, Leslie Shanks
1
1Me ´decins Sans Frontie `res, Amsterdam, The Netherlands, 2Me ´decins Sans Frontie `res, Lubumbashi, Democratic Republic of Congo, 3Ministe `re de Sante ´, Division
Province du Katanga, Lubumbashi, Democratic Republic of Congo, 4University of Auckland, Auckland, New Zealand, 5Institute for Social Medicine, Epidemiology and
Health Economics, Charite ´ University Medical Centre, Berlin, Germany
Abstract
Background: Catch-up growth after an infection is essential for children to maintain good nutritional status. To prevent
malnutrition, WHO recommends that children are given one additional healthy meal per day during the 2 weeks after onset
of illness. We investigated to what extent ready-to-use therapeutic food (RUTF) promotes catch-up growth in children after
an acute, uncomplicated episode of Plasmodium falciparum malaria.
Methods: We did an open randomised trial of children aged 6–59 months with confirmed malaria who attended a Me ´decins
Sans Frontie `res-supported outpatient clinic in Katanga Province, Democratic Republic of Congo. All children received a
clinical examination and malaria treatment. Patients were then randomly assigned to either an RUTF group, who received
daily supplemental RUTF (a high-protein peanut-based paste) for 14 days, or to a control group, who received no
supplemental food. Children were weighed at baseline and on days 14 and 28. The primary outcome was mean weight
change after 14 days’ RUTF. Analysis was by intention-to-treat.
Results: 93 children received RUTF and 87 received no food supplementation. At day 14, the RUTF group had a mean
weight gain of 353 g compared with 189 g in the control group (difference 164 [95%CI 52–277], p=0.005). However, at
day 28 there was no statistically significant difference between the groups (539 g versus 414 g, respectively [p=0.053]).
Similarly, rate of weight gain per kg bodyweight per day was significantly higher at day 14 in the RUTF group (2.4 g/kg per
day versus 1.3 g/kg per day, p=0.005) but at day 28 was 1.9 g/kg per day in the RUTF group versus 1.5 g/kg per day in the
control group (p=0.076).
Conclusions: Children receiving RUTF for 14 days after effective treatment of an uncomplicated malaria episode had a faster
weight gain than children not given supplementation, reducing the period that children were at risk of malnutrition.
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Introduction
The causes of malnutrition are multifactorial, involving not only
an inadequate diet but also recurrent infections [1,2]. Young
children have an especially high susceptibility to acute infectious
diseases such as malaria, diarrhoea, and acute respiratory
infections, which are generally associated with weight loss [3].
This occurs because infections can decrease food intake due to
poor appetite, impair nutrient absorption, cause direct nutrient
losses by diarrhoea or vomiting, increase metabolic requirements
or catabolic losses [4], and impair transport of nutrients to target
tissues. If disease-associated weight loss is not prevented or
compensated for, it can lead to longer-term effects on nutrition
[2,5]. This weight loss, in turn, increases susceptibility to further
infections, perpetuating a cycle towards a further reduced
nutritional state [3,5–8].
Effects of short-term weight loss during episodes of acute
infection can be mitigated by good nutrition, allowing for
successful convalescence and adequate catch-up growth [9,10].
To prevent malnutrition, WHO recommends that children are
given one additional healthy meal daily during the 2 weeks after
the onset of illness [11]. However, in many developing countries
this strategy is unlikely to be effective, since the ingredients
necessary for a healthy meal are often not available. Therefore, a
more effective strategy in resource-poor areas could be to provide
nutrient-rich high-quality food supplements for ill children. Other
than a study in Gambia [10], there has been little evidence to
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loss in children with acute diarrhoea was effectively treated by
providing a supplement enriched with vitamins and minerals for
2 weeks [10]. In the group that did not receive supplementation,
no significant overall weight gain occurred. This finding raised the
question of whether supplementation with a nutrient-rich food
would also be effective for convalescence after infections other
than acute diarrhoea, such as malaria.
The following hypothesis was therefore tested: children aged 6–
59 months with confirmed P falciparum malaria who are provided
with a RUTF supplement (Plumpy’nut) of 500 kcal per day for
14 days will show significantly better weight gain after 14 and
28 days compared to a similar patient group not provided with
RUTF.
Plumpy’nut (Nutriset, Malaunay, France) is an industrially
produced high-quality nutritional supplement that has been shown
to promote weight gain in malnourished children [12]. The
treatment is an individually packed lipid based paste made up of
peanuts, milk powder, sugar, oil, and fortified with micronutrients.
Although the supplement contains iron and folic acid, no adverse
effects have been reported on either the incidence or severity of
malaria [12].
Malaria kills more than a million people annually, with children
under 5 years of age being the most vulnerable. More than 90% of
malaria deaths occur in Africa, where around two-thirds of the
population are at high risk of infection [13]. We assessed the effect
of a 14-day distribution of ready-to-use therapeutic food (RUTF)
on weight gain in children after an episode of acute uncomplicated
Plasmodium falciparum malaria. This study was a pilot to guide
further research on the effect of supplementation in various
diseases and settings.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Study location and participants
This study took place in the outpatient department (OPD) of the
Centre de Sante ´d eR e ´fe ´rence Mutabi–a referral hospital
supported by Me ´decins Sans Frontie `res (MSF)–in Dubie ´, Katanga
Province, southern Democratic Republic of Congo. Dubie ´i s
situated in a forest region. There is no defined hunger season, with
people able to cultivate maize, sorghum, cassava, beans, leafy
greens and fruits throughout the year. In addition, fish and poultry
products are regularly available. Though this can be interrupted
by periods of conflict, forcing the population to flee into the forest
and thus abandoning their crops, the area experienced relative
calm before and during the study period. The study was conducted
just after harvesting of mangos, a rich source of vitamins.
Breastfeeding is commonly practiced, although foods of limited
nutritional value (incl. water-based porridges) are introduced as
early as 3 months of age. In addition, children weaned from
breastfeeding often do not receive milk and other high quality
foods.
The major childhood diseases are diarrhea, respiratory tract
infections and malaria. Malaria is endemic throughout year with
peak periods between September and March. In 2007, 54 671
children under 5 years of age consulted the outpatient department,
of whom 21 939 (40%) were treated for uncomplicated malaria.
Amongst total malaria cases seen in the OPD, approximately half
occur in children under 5 years of age.
Inclusion criteria included children age 6–59 months, present-
ing at the OPD, confirmed uncomplicated Plasmodium falciparum
malaria, and voluntary informed written consent from the
caretaker. Exclusion criteria included exclusive breastfeeding,
severe malnourishment (middle-upper arm circumference of less
than 110 mm and/or bilateral oedema or a weight-for-height z-
score [WHZ] of less than –3 [WHO 2005 reference]; signs of
severe malaria as defined by WHO guidelines, a known history of
allergy to malaria drugs, a sibling enrolled in the study, living
further than 30 minutes walking distance from the clinic, and
severe illness or needing hospitalisation. Patients were withdrawn if
they met any of the exclusion criteria during the study, or if they
failed to complete the malaria treatment schedule. Informed
consent was obtained by reading the consent form aloud in French
or the appropriate local language.
Study procedures
At point of entry into the OPD clinic, all children with suspected
uncomplicated malaria (defined as having a fever greater than
38.0uC, a reported history of fever within the past 48 hours, or
both), were screened using the P. falciparum rapid diagnostic test
(RDT), Paracheck (Orchid Biomedical System, Goa, India), by the
routine non-study clinical staff. Children were then seen by a non-
study clinician for routine clinical examination and treatment.
Children positive for malaria by RDT were referred and
accompanied to the study clinic, located in the same compound.
The number of children presenting at the OPD clinic with
suspected malaria regularly exceeded the study team’s daily
screening capacity. Therefore, depending on the daily estimation
of patients attending the OPD clinic, the study coordinator
systematically used a selection interval of every second or third
child arriving at the study clinic to screen for study inclusion. To
minimise risk of selection bias, OPD staff were not informed of the
day’s selection interval. Thick blood film microscopy was used as
the gold standard to confirm infection with P falciparum malaria.
Children who tested negative by microscopy were excluded from
the study, and those who were positive were further screened for
inclusion.
All recruited children were randomly assigned to either an
RUTF group (hereafter referred to as RUTF group) receiving
RUTF (500 kcal per day for 14 days) or to a control group without
food supplementation. 200 numbered pieces of paper of equal size
and weight were placed into a cloth bag, and a number was drawn
out by the study coordinator in front of the caretaker and child. All
even numbers were allocated to the RUTF group and odd
numbers allocated to the control group. Once the number was
allocated it was removed. This method was chosen to reduce the
risk of misunderstanding or suspicion in a setting where the study
population would likely not have understood the logic of a
computer generated allocation scheme. With the use of standard
labelled RUTF packets, blinding of participants and clinic staff
was not practical. Staff performing weight measurements and
laboratory testing were blind to study group allocation.
Upon inclusion, all children received malaria treatment as per
local MoH/MSF protocol (artesunate 4 mg/kg for 3 days plus
amodiaquine 10 mg/kg a day for 3 days). Malaria treatment was
directly supervised (DOTS) at the study clinic for the three
consecutive days. Microscopy was repeated on the third day to
confirm parasite clearance. Those patients remaining slide-positive
on the third day were asked to return each day until parasite
clearance was microscopically confirmed or treatment failure was
established.
At study inclusion, anthropometric data were collected and a
detailed questionnaire was completed to obtain background and
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RUTF, with the first sachet opened in the clinic and instructions
given to the caretaker to guide proper use. Adherence to the food
supplement was measured in three ways: the caretakers were asked
how many sachets the child had consumed, how many days the
sachets were consumed, and to bring back the empty sachets to the
clinic. Weight measurements were taken at inclusion (day 0),
day 14, and day 28, using an electronic weighing scale (SECA
model 835, Seca Corporation, Hamburg, Germany). A detailed
questionnaire and medical exam were completed on day 14 and
day 28. To minimise differences in weight within the day, routine
follow-up visits and weighing activities were scheduled for the
same time of day as the first visit, and the caretakers were
reminded by a home visitor a day before their scheduled
appointment.
Caretakers were encouraged to bring their children to the study
clinic at any time if they had questions or felt that they needed
medical care. In line with WHO recommendations, all caretakers
were informed about the importance of giving sick children an
additional healthy meal per day for 14 days. All participants who
completed the study received an insecticide impregnated bednet
and soap to compensate for participation.
The primary outcome was weight change (g) from day 0 to
day 14. Secondary outcomes included: weight change from day 0
to 28, and from day 14 to 28; rate of weight gain (g/kg per day) at
day 14 and 28; the proportion of children with any weight gain,
and contribution of other factors to convalescence after an episode
of malaria. The study questionnaire for each clinical visit captured
key health indicators for the two weeks prior to clinical visit,
including cough, fever, diarrhoea, vomiting and appetite. A
household wealth score was calculated using the possession of
specified household items (incl. bicycle, watch, radio, and
generator) and livestock.
Various measures ensured the quality of the data collected,
including patient files kept on site for future visits; establishing a
pattern of patient flow to ensure efficiency and reduce risk of
contamination; continuous monitoring and training of staff; data
entry on the same evening of the patient visit, allowing for
clarification the following day; double data entry after completion
of the study.
Laboratory
Blood smears for microscopic detection of parasites were stained
with 10% pre-filtered Giemsa. Asexual parasites were counted
Figure 1. Trial profile.
doi:10.1371/journal.pone.0035006.g001
Therapeutic Food for Catch-Up Growth in Children
PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e35006against 200–500 leucocytes and converted to number of parasites
per volume assuming 8,000 leucocytes/mL blood. Slides were
considered negative when no parasites were detected after viewing
100 microscopic fields. Microscopists, unaware of study allocation,
read all slides. Internal quality control included a blind second
reading of a proportion of the slides, as per MSF protocols [14].
External quality control consisted of a random sample of 20%
blood slides sent to an external reference laboratory (Path Care,
Nairobi Kenya).
Statistical analysis
Parameters for the sample size calculation were, in part, based
on the result of a previous supplementation study of children with
diarrhoea [10]. We extrapolated the evidence that nutritional
supplementation would address weight gain related to a malaria
infection in a manner similar to that seen by Hoare and colleagues
for diarrhoeal disease [10].
Parameters used for initial sample size calculations included a
power of 80%, a 5% level of significance for a two-sided t-test, and
an assumed mean weight gain after 14 days of 0.09 kg (SD 0.44) in
the control group and 0.44 kg (SD 0.33) in the RUTF group [10].
This resulted in a sample size of 24 participants per study group
(STATA software, version 8). With no clear data on weight change
amongst malaria cases, and using 24 participants per study group
as a minimum, we worked to define the highest number of
participants logistically feasible to enrol during the available four
week period. This resulted in 100 per group (including 20
additional children for potential lost to follow up and withdrawals
from the study).
Statistical analysis was completed based on a parallel RCT
design with an allocation ratio of 1:1 and an intention to treat
principle. To verify the randomization assumption, we compared
the prevalence of baseline characteristics between the two study
groups. Graphical methods were used to test for normality of
baseline and outcome variables, including histograms and box
plots. Mean weight changes and other continuous variables were
compared by two-sample t-test (two-sided), and categorical data
were analysed using Pearson’s chi-squared test with continuity
correction or Fisher’s exact test if frequencies were small. Median
and interquartile range (IQR) were reported for discrete data.
Presence of outliers and their impact were assessed. Statistical
analysis was completed using STATA version 8.2. The likelihood
ratio test (LRT) was used to assess effect modification, recognising
that tests for effect modification are known to have limited
statistical power. The statistician was not blinded to allocation.
A limited number of variables were investigated for effect
modification, including household socioeconomic status; maternal
breastfeeding practices; child’s age, sex, and nutritional status. We
estimated adjusted means and odds ratios from generalized linear
mixed-effects models with weight gain as the outcome. Predictors
included household socioeconomic status, maternal age and
education, child’s age and sex, breastfeeding practices, appetite,
nutritional status, and duration (days) of malaria clinical symptoms
Table 1. Baseline characteristics.
RUTF Control
Number 93 87
Female
a 36 (38.7%) 44 (50.6%)
Age (months)
b 29.6 (14.5) 28.0 (14.7)
Age #36 months
a 56 (60.2%) 54 (62.0%)
Breastfeeding, partial
a,d 21 (22.6%) 32 (36.8%)
Days of illness before visit
c 2.8 (2, 2–3) 3.2 (3, 2–3)
Fever
a,e 86 (92.5%) 82 (94.3%)
Parasite density
b 37 414 (59 302) 37 089 (52 317)
Cough
a,e,f 48 (51.6%) 47 (54.0%)
Diarrhoea
a,e, g 5 (5.4%) 6 (6.9%)
Vomiting
a,e, h 5 (5.4%) 2 (2.3%)
Appetite less than normal
a,e 77 (82.8%) 60 (69.0%)
Weight (kg)
b 10.24 (2.40) 10.20 (2.53)
Weight-for-height z-score
b 20.53 (1.00) 20.46 (0.99)
Weight-for-height z-score ,22
a 6 (6.8%) 5 (5.8%)
MUAC (mm)
b 149 (13) 151 (11)
Weight-for-age z-score
b 21.91 (1.10) 21.72 (1.18)
Height-for-age z-score
b 22.67 (1.46) 22.48 (1.46)
Mother is caretaker
a 80 (86.0%) 77 (88.5%)
Age (years)
b 28.9 (9.9) 29.1 (8.2)
No education
a 27 (29.0%) 20 (23.0%)
More than 4 years primary school
level
a
42 (46.7%) 39 (45.2%)
Occupation agriculture
a 78 (88.6%) 69 (80.2%)
Partner’s occupation agriculture
a 51 (57.9%) 45 (52.3%)
Household wealth score
c 1.7 (2, 1–3) 1.7 (2, 1–3)
Less than two meals previous day
a 25 (26.9%) 33 (37.9%)
Number of meals previous day
c 1.69 (2, 1–2) 1.73 (2, 1–2)
RUTF: ready-to-use therapeutic food. MUAC: middle-upper arm circumference.
aNumber (%).
bmean 6 SD: standard deviation.
cmean (median, IQR: interquartile range).
d91 patients analysed in the intervention group and 83 in the control group.
symptom in the 14 days prior to study inclusion.
faxillary temperature .38uC.
g3 or more liquid stools in any 24 hour period.
hoccasional persistent vomiting.
doi:10.1371/journal.pone.0035006.t001
Table 2. Mean weight gain (g).
RUTF Control Difference p-value
Day 0–14
a,b 352.7 (275.4–430.1) 365.0 188.6 (105.7–271.5) 386.8 164.1 (51.6–276.6) 0.005
Day 14–28
a,c 187.1 (125.9–248.3) 287.1 228.6 (166.6–290.5) 285.2 241.4 (2127.9–250.7) 0.345
Day 0–28
a,c 539.3 (447.8–630.8) 428.2 414.3 (325.9–502.7) 407.5 125.0 (21.4–251.4) 0.053
amean (95% CI) SD.
bRUTF n=88, control n=86.
cRUTF n=87, control n=84.
doi:10.1371/journal.pone.0035006.t002
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potential confounders showed no statistical, clinical, or operational
difference in results. As such, we report only unadjusted results.
Results
Between January 6 and February 16, 2009, 394 children with
suspected malaria were referred to the study clinic. Of these, 200
were screened for eligibility, including microscopy for confirma-
tion of active malaria infection; the 194 who were not screened
received a medical exam and appropriate treatment. During the
screening process, twenty children were excluded: one did not
meet the inclusion criteria, three chose to not participate after the
being informed through the consent procedure, and 16 had blood
slide results that were negative for malaria.
The 180 participants who were recruited were randomly
assigned by the study coordinator to either the control group
(n=87) or the RUTF group (n=93; Figure 1). The study was
stopped early due to unexpected field constraints related to
changes in security. This resulted in a total recruitment meeting
the minimum sample size of 180 children and an unequal
distribution of children per study group.
Quality control on the 20% of malaria microscopy slides
checked by the reference laboratory revealed an agreement of
97.5%. Discrepancies in microscopy would not have impacted
participant inclusion or treatment decisions.
At 14 days, all patients in the RUTF group were reported to
have eaten ten or more of the fourteen RUTF sachets received at
inclusion 82 (93.2%) caretakers in the RUTF group reported that
their child had eaten all 14 RUTF sachets, with 76 (84.4%)
returning all empty sachets. During return visits, all but three
participants were weighed at the same time of day as previously
(within a 3 hour margin). The three participants who presented
outside these time limits returned the day after their appointment
at the right time; the weight gain rate was calculated over this
period.
The average age of the children was 28.8 (SD 14.6) months, and
was similar for both groups. 44.4% (80) of participants were girls.
Through verifying the randomisation assumption for distribution
of baseline characteristics, three variables were noteworthy
without being statistically significant. These include a higher
percentage of girls in the control group (50.6%, 38.7%), more
reported vomiting in the RUTF group (5.4%, 2.3%) and a greater
proportion of households in the control group eating less than two
meals during the previous day (37.9%, 26.9%). An additional two
variables showed statistically significant difference at baseline,
including more children in the control group being partially
breastfed (36.8%, 22.6%; p=0.03) and more children in the
RUTF group having a less than normal appetite (82.8%, 69.0%;
p=0.03). Controlling for these potential confounders showed no
statistical, clinical, or operational difference. For this reason, we
chose not to adjust for potential confounders. The nutrition
indicators were similar for both groups, with a total mean WHZ
,20.50 (WHO 2005 reference). 11 (6%) children had a WHZ
below-2 (WHO 2005 reference). The mean weight-for-age z-score
was-1.82 and height-for-age z-score was-2.58 (WHO 2005
reference; Table 1).
The child was most often accompanied by the mother to the
clinic, with other relations including grandparents, fathers, and
siblings (Table 1). Caretaker socio-demographics and household
wealth scores did not differ significantly by group, with the two
study groups having an equal median and IQR (median: 2, IQR:
1–3). At inclusion, the reported number of meals eaten per
household during the day before the interview ranged between 0
and 3 meals, with the study groups having equal median and IQR
(median: 2, IQR: 1–2). 122 (67.7%) caretakers reportedly
consumed 2–3 meals. Only one household in the RUTF group
reportedly ate no meal during the day before the interview.
Nine children were withdrawn or lost to follow-up: six from the
RUTF group and three from the control group. One participant
in the RUTF group was lost to follow-up on day 14 (reason
unknown), and one at day 28 when the caretaker went with the
child to the lake to fish. Four participants in the RUTF group were
withdrawn: one because the caretaker reported that the child did
not receive the supplement (child was healthy with appetite), two
due to admission to hospital, and one due to death. A thorough
case evaluation of the death revealed that the cause was not related
to study activities. In the control group, one patient was lost to
follow-up on day 14 and one on day 28 because of agriculture and
fishing activities. On day 20, one child was withdrawn due to
illness and subsequent admission to hospital (Figure 1). There were
no malaria treatment failures.
Weight gain
At day 14, mean weight gain was significantly higher in the
RUTF group (352.7 vs 188.6 g in the control group; difference
Table 3. Mean rate of weight gain (g/kg per day).
RUTF Control Difference p-value
Day 0–14
a,b 2.36 (1.85–2.87) 2.40 1.29 (0.75–1.84) 2.53 1.07 (0.33–1.81) 0.005
Day 14–28
a,c 1.37 (0.90–1.82) 2.12 1.70 (1.28–2.12) 1.95 20.33 (20.95–0.29) 0.293
Day 0–28
a,c 1.87 (1.55–2.18) 1.47 1.48 (1.19–1.77) 1.35 0.389 (20.04–0.81) 0.076
amean (95% CI) SD.
bRUTF n=88, control n=86.
bRUTF n=87, control n=84.
doi:10.1371/journal.pone.0035006.t003
Table 4. Number gaining any weight (.0 g).
RUTF Control Odds ratio
b p-value
Day 0–14
a,c 74 (84.1) 61 (70.9) 2.17 (1.04–4.52) 0.040
Day 14–28
a,d 64 (73.6) 67 (79.8) 0.71 (0.35–1.44) 0.340
Day 0–28
a,d 79 (90.8) 77 (91.7) 0.90 (0.31–2.60) 0.842
an( % ) .
bOR (95% CI).
cRUTF n=88, control n=86.
dRUTF n=87, control n=84.
doi:10.1371/journal.pone.0035006.t004
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gain at day 28 was still higher in the RUTF group, with a
difference approaching statistical significance (difference 125.0 g
[95% CI-1.4 to 251.4], p=0.053).
The rate of weight gain was also significantly higher in the
RUTF group (2.36 vs 1.29 g/kg per day p=0.005) during the
supplementation period (days 0–14), although it was slightly
higher in the control group during days 14–28 (1.37 vs 1.07 g/
kg per day, p=0.293). After 28 days, the RUTF group showed a
higher overall rate of weight gain (1.87 vs 1.48 g/kg per day), with
a difference approaching statistical significance (p=0.076;
Table 3).
A higher proportion of children in the RUTF group gained any
weight (i.e. weight gain.0 g) than in the control group at day 14
(84.1% vs 70.9%; odds ratio [OR] 2.17, 95% CI 1.04–4.52;
p=0.040). However, during the 14-day follow up after the
supplementation ended, a smaller proportion of children in the
RUTF group gained weight compared with the control group
(73.6% vs 79.8%; OR 0.71, 95% CI 0.35–1.44; p=0.340),
although this was not significant. Within the total 28 day study
period, an almost equal proportion of children gained any weight
in the RUTF and control groups (90.8% vs 91.7%; OR 0.90, 95%
CI 0.31–2.60; p=0.842; Table 4).
Gender and breastfeeding were identified as effect modifiers.
Though likelihood ratio tests (LRT) did not show statistical
significance, results at day 14 showed girls in the RUTF group
with a much higher rate of weight gain than the males (1.80 g/kg/
day (95%CI: 0.54–3.06) vs 0.49 g/kg/day (95%CI: 0.39 to 1.38),
respectively). A notable difference was also recorded after 28 days
of follow up. The rate of weight gain at day 14 was also much
higher amongst children in the RUTF group who were not
breastfed compared to children partially breastfed (1.24 g/kg/day
(95%CI: 0.31–2.18) vs 0.30 g/kg/day (95%CI: 0.89–1.49) respec-
tively). A similar difference was also recorded after 28 days of
follow up. (Tables 5 and 6).
Amongst those reporting reduced appetite at inclusion, the rate
of weight gain at day 14 was 2.46 g/kg per day in the RUTF
group and 1.11 g/kg per day in the control group (p=0.001),
whereas children in the two groups reporting normal or better
appetite during the same time period had similar rates of weight
gain: 1.88 g/kg per day in the RUTF group and 1.76 g/kg per
day in the control group (p=0.843).
As shown in Table 7, there were no significant differences
between study groups in the proportion of children reporting
fever, diarrhoea or vomiting. However, there were notable
differences with reported cough. While both groups showed a
reduction in children reporting cough after 14 days of follow-up,
the proportion of children with cough was significantly lower in
the RUTF group than in the control group (18.2% vs 37.2%;
p=0.006; Table 7). Additionally, while a similar proportion of
children in both groups reported a reduced appetite at study
inclusion, a significantly smaller proportion from the RUTF group
reported reduced appetite at day 14. After 28 days, there was no
difference in reported cough and appetite between the RUTF and
control groups (Table 7).
Discussion
Our findings indicate that 14 days of RUTF supplementation in
children with malaria promotes increased rate of weight gain and a
shorter period of convalescence, as shown by a significantly higher
proportion of children reporting recovery from cough and
improved appetite amongst children receiving RUTF supplemen-
tation. After 14 days, the RUTF group gained, on average, more
weight and at a faster rate than children not receiving supplement,
with the control group gaining close to the 1.4 g/kg/day expected
amongst well children [15]. With the greater proportion of
children gaining any weight in the RUTF group during the first
Table 5. Mean rate of weight change (g/kg per day), stratified by sex.
RUTF
a Control
a Difference
b p value
¥
Day 0–14 Female 2.83 (1.92–3.75) 34 1.03 (0.16–1.90) 44 1.80 (0.54–3.06)
Male 2.06 (1.46–2.67) 54 1.57 (0.90–2.22) 42 0.49 (0.39–1.38) 0.163
Day 0–28 Female 2.15 (1.62–2.67) 34 1.39 (0.95–1.82) 44 0.76 (0.09–1.43)
Male 1.68 (1.29–2.08 ) 53 1.58 (1.18–1.99 ) 40 0.10 (20.46–0.67) 0.215
aMean (95% CI) n.
bMean (95% CI).
¥likelihood ratio test (LRT) for effect modification.
doi:10.1371/journal.pone.0035006.t005
Table 6. Mean rate of weight change (g/kg per day), stratified by breastfeeding.
Breastfeeding RUTF
a Control
a Difference
b p value
¥
Day 0–14 yes 1.42 (0.35–2.50) 20 1.12 (0.43–1.82) 32 0.30 (0.89–1.49)
no 2.64 (2.06–3.21) 68 1.39 (0.61–2.17) 54 1.24 (0.31–2.18) 0.230
Day 0–28 yes 1.60 (0.89–2.33, 20 1.40 (0.99–1.82) 30 0.19 (20.57–0.95)
no 1.95 (1.60–2.30) 67 1.52 (1.12–1.92) 54 0.43 (0.10–0.95) 0.490
aMean (95% CI) n.
bMean (95% CI).
¥likelihood ratio test (LRT) for effect modification.
doi:10.1371/journal.pone.0035006.t006
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reducing the period that a child is in a vulnerable state.
Contributing to this vulnerability is the depletion of nutritional
elements, including proteins, essential fatty acids and essential
micronutrients (incl. zinc, vitamins C, E vitamins and B), during
active infection. This can decrease immunity and complicate
recovery [16]. Infections, including malaria, are associated with
anorexia and weight loss. With marginal micronutrient stores, two
causes of disease-related anorexia and weight loss arise: i.) infection
dependent regulation of appetite and ii.) secondary micronutrient
deficiency.
Firstly, an infection-activated immune system increases cytokine
production, particularly tumour necrosis factor (TNF) which is
associated with anorexia. In the absence of micronutrients,
essential for the regulation of the immune system, anorexia can
persist unchecked.
Secondly, a highly active immune system increase the use of
micronutrients, including the micronutrients (zinc, selenium) that,
when deficient, are associated with decreased appetite and
stunting. A supplementation of micronutrients, proteins and
energy adds extra nutrients to mitigate the secondary deficiencies
and promote weight gain. This is further supported by results
showing a greater weight increase amongst children who reported
low appetite at inclusion.
Similar to the results on weight gain, cough was significantly
reduced at day 14 in the RUTF group compared with the control
group. However, after 28 days, cough was equally reduced in both
groups. These results suggest that food supplementation promotes
a shorter convalescence with recovery of cough in children with
malaria, giving hope that this approach could be effective amongst
children with other diseases. Research shows also that micronu-
trient supplementation plays an important role in recovery from
disease (eg, zinc contributes to the cure of and is protective for
diarrhoea and pneumonia).
In settings of poor food security, one could expect to see even
greater weight gain than that seen in this study. The relatively
stable food security in the Dubie region might have enabled
caretakers to provide adequate, or even additional, food for the
children recovering from malaria. This likely contributed to a
smaller positive impact of RUTF, given that the baseline
nutritional state of a child will influence the effect of supplemen-
tation. At the time of the study, active agriculture was occurring
and the overall food security situation in Dubie ´ was fairly stable. In
addition, an observed low prevalence of moderate malnutrition in
children screened for study inclusion indicates a fairly good overall
nutritional situation during the study period.
As an effect modifier, the slower rate of weight gain seen among
partially breastfed children may be explained, in part, by the fact
that breastfeeding limits weight loss during illness, thus reducing
the amount of weight needed to be gained to attain pre-illness
weight. A study by Brown et al. amongst sick children showed that
breast-milk intake was close to normal, while intake of food (not
breast milk) was significantly reduced amongst similar (non-
breastfed) children [17]. In light of this and the risk that
supplementation could disrupt healthy breastfeeding practices,
further discussion and research is warranted as to the role of
supplementation amongst breastfed children.
While the mean weight gain itself is likely not of clinical
importance, for children with an already low weight and marginal
nutrition state, such small improvements in weight gain and
shorter convalescence are important for healthy recovery,
decreased vulnerability, and decreased risk of malnutrition.
Supplementation breaks the vicious cycle of malnutrition and
disease; firstly by preventing or rapidly mitigating nutritional
depletion during recovery and secondly by shortening the
convalescence period after infection. While this study highlights
the possible benefits, larger studies are needed to further confirm
that supplementation to ill children can be a key contributor to
reducing incidence of malnutrition and disease.
Limitations
Mean weight gain is likely not the optimum outcome measure
for measuring the effect of a supplementation on nutritional
health. The incidence of malnutrition and of morbidity would
more accurately measure the effectiveness of supplementation in
Table 7. Children having a symptom in the 2 weeks before day 0, at day 14, and at day 28.
Fever
c Cough Diarrhoea
d Appetite , normal
Day 0 RUTF
a 86 (92.5%) 48 (51.6%) 5 (5.4%) 77 (82.8%)
Control
a 82 (94.3%) 47 (54.0%) 6 (6.9%) 60 (69.0%)
OR
b 0.75 (0.23–2.45) 0.91 (0.50–1.63) 0.77 (0.22–2.61) 2.16 (1.07–4.38)
p-value 0.630 0.746 0.671 0.032
Day 14 RUTF
a 5 (5.7%) 16 (18.2%) 4 (4.6%) 4 (4.5%)
Control
a 8 (9.3%) 32 (37.2%) 7 (8.1%) 12 (14.0%)
OR
b 0.59 (0.18–1.87) 0.38 (0.19–0.75) 0.54 (0.15–1.91) 0.30 (0.09–0.950)
p-value 0.368 0.006 0.336 0.041
Day 28 RUTF
a 6 (6.9%) 10 (11.5%) 4 (4.6%) 3 (3.5%)
Control
a 11 (13.1%) 12 (14.3%) 4 (4.8%) 4 (4.8%)
OR
b 0.49 (0.17–1.40) 0.78 (0.32–1.91) 0.96 (0.23–3.98) 0.71 (0.15–3.29)
p-value 0.182 0.590 0.959 0.666
Vomiting 8 cases in total: not reported.
aNumber (%).
bOR (95% CI).
caxillary temperature .38uC.
cDescribed as 3 or more liquid stools in any 24 hour period.
doi:10.1371/journal.pone.0035006.t007
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children.
With neither patient nor clinician blinded to group allocation,
there is the risk of reporting and treatment bias. Monitoring of
adherence to supplementation through caretaker interview and
counting empty sachets at day-14 cannot definitively determine if
the product was consumed by the targeted child, for example.
Teams worked to keep such limitations to a minimum through
standard health messages during clinic visits. However, the
intention of this effectiveness study was to measure the impact of
supplementation in a typical OPD setting, where such limitations
are difficult or impossible to control.
Conclusions
Children receiving ready-to-use therapeutic food for 14 days
after an uncomplicated episode of malaria had a faster weight gain
and recovery from illness than children not given supplementation,
reducing the period that children were at risk of malnutrition.
Although these findings are not adequately robust to justify
general distribution of RUTF supplementation to a wider
population (i.e. children using outpatient services with confirmed
malaria and not severely malnourished) in settings similar to
Dubie ´, additional food supplementation with RUTF for sick
children is a likely scenario in precarious settings with inadequate
food security or a high prevalence of malnutrition.
The use of RUTF warrants further investigation, since these
results cannot yet be generalised to situations with different levels
of food security or extrapolated to other diseases. While giving
indication to the positive effect of supplementation with RUTF on
malnutrition and disease, the study does not give precise answers
on which patient subgroups (e.g. identified by age, nutritional
status, or illness) might benefit most from such supplementation.
Further study is needed in order to investigate whether food
supplementation to sick children can lower the incidence of
malnutrition and disease in a context with a lower nutritional
status.
For reasons of cost-effectiveness, we need to investigate whether
multi-micronutrient supplementation alone would have had a
similar effect as RUTF. If nutritional supplementation is proven to
be effective, either food or micronutrients alone should be
considered as an additional treatment for children with serious
diseases such as lower respiratory tract infection, malaria, and
diarrhoea.
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